Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medtronic enrols first patient in heart rhythm trial

Medtronic enrols first patient in heart rhythm trial

26th September 2012

Medtronic has announced the commencement of patient enrolment for a global trial that aims to establish new ways of improving treatment of heart rhythm abnormalities.

The first patient has been recruited for the Improve Brady trial, which will evaluate the impact of physician-led improvement initiatives on the diagnosis and treatment of patients with a common abnormal heart rhythm in nine emerging market countries.

Over the course of the study, physicians will employ evidence-based guidelines and recommended therapies to treat underserved populations through standardised healthcare processes and patient education.

The findings of this study will aid the future treatment of patients with sinus node dysfunction in poorer countries, where this issue can prove a serious health risk.

Pat Mackin, president of the cardiac rhythm disease management business and senior vice-president at Medtronic, said: "We are committed to improving patient care and providing access to clinically-validated medical solutions in emerging markets."

Earlier this month, the company published data from Improve HF, a study which demonstrated the benefits of evidence-based medication and device therapy for heart failure patients.ADNFCR-8000103-ID-801457652-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.